Skip to main content
. 2023 Feb 23;14:1041. doi: 10.1038/s41467-023-36683-x

Fig. 5. An Anti-AD-6 antibody is non-neutralising against cell-free CMV.

Fig. 5

a, b Serial dilutions of anti-AD-6 pAb were incubated with Merlin (a), Merlin in the presence of complement (b) for 1 hour then used to infect HFFs (MOI = 1) and infection scored by IF for IE gene expression. Infection was expressed relative to infection in a no antibody control. c, d Serial dilutions of anti-AD-6 pAb were incubated with TB40/E (c), TB40/E in the presence of complement (d) for 1 hour then used to infect ARPE-19 cells (MOI = 2) and infection scored by IF for IE gene expression. Infection was expressed relative to infection with a no antibody control. For all experiments (a–d) n = 3 represents the mean of three independent experiments which included biological triplicates within each experiment. The error bars represent 1 standard deviation from the mean.